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ABSTRACT
Repression of poly(A)-binding protein (PABP) mRNA
translation involves the binding of PABP to the
adenine-rich autoregulatory sequence (ARS) in the
50-untranslatedregionofitsownmRNA.Inthisreport,
we show that the ARS forms a complex in vitro with
PABP, and two additional polypeptides of 63 and 105
kDa.The63and105kDapolypeptideswereidentified,
asIMP1,anorthologofchickenzip-codebindingpoly-
peptide, and UNR, a PABP binding polypeptide,
respectively, by mass spectrometry of the ARS RNA
affinity purified samples. Using a modified ribo-
nucleoprotein (RNP) immunoprecipitation procedure
we further show that indeed, both IMP1 and UNR bind
to the ARS containing reporter RNA in vivo. Although
both IMP1 and UNR could bind independently to the
ARSRNAinvitro,theirRNA-bindingabilitywasstimu-
lated by PABP. Mutational analyses of the ARS show
that the presence of four of the six oligo(A) regions of
the ARS was sufficient to repress translation and the
length of the conserved pyrimidine spacers between
the oligo(A) sequences was important for ARS func-
tion. The ability of mutant ARS RNAs to form the
PABP, IMP1 and UNR containing RNP complex corre-
lates well with the translational repressor activity of
the ARS. There is also a direct relationship between
thelengthofthepoly(A)RNAsandtheirabilitytoform
a trimeric complex with PABP, and to repress mRNA
translation. UV crosslinking studies suggest that the
ARS is less efficient than a poly(A) RNA of similar
length, to bind to PABP. We show here that the ARS
cannotefficientlyformatrimericcomplexwithPABP;
therefore, additional interactions with IMP1 and UNR
to form a heteromeric RNP complex may be required
for maximal repression of PABP mRNA translation
under physiological conditions.
INTRODUCTION
Poly(A)-binding protein (PABP) is a highly conserved, abun-
dant and ubiquitous RNA-binding protein which preferentially
associates with the 30-poly(A) tail of eukaryotic mRNA. PABP
also interacts with other cytosolic proteins such as Rna15 (1),
eIF4B (2), eIF4G (3), eRF3 (4), Paip1 (5), Paip2 (6), TcUBP-1
(7), UNR (8) and poly(C)-binding proteins (9). Almost all
known functions of PABP are attributed to its ability to inter-
act with the 30-poly(A) tract and to act as a scaffold for
protein–protein interactions. PABP contains four highly con-
served RNA-binding domains (RBDs I–IV) arranged in tan-
dem at the N-terminus, followed by a less conserved proline-
rich auxiliary domain of variable length at its C-terminus (10).
The ﬁrst two RBDs towards the N-terminus (RBD-I/II) exhibit
preferential afﬁnity for poly(A) RNA, whereas the RBDs
towards the C-terminus (RBD-III/IV) show tropism for
poly(U) RNA (11–13). The C-terminal region, which contains
a highly conserved 74 amino acid-long PABC domain
(14), does not bind RNA but interacts with other polypeptides
as well as promotes oligomerization of PABP on poly(A)
RNA (15).
PABP has been implicated in global gene regulation both by
stimulatingtranslationinitiation(16)andbyenhancingmRNA
stability (17). A popular hypothesis addressing the mechanism
of translation stimulation focuses on the connection between
the 30-poly(A) tail bound PABP and the 50-cap bound eIF4F
holoenzyme. eIF4F is a ternary complex consisting of RNA-
helicase eIF4A and 50-cap binding protein eIF4E, connected
together by a central scaffold proteineIF4G (18).According to
this model, interaction between PABP and eIF4G results in
mRNA circularization, thereby promoting recycling of termi-
nating ribosomes from the 30 end to the 50 end for another
round of translation initiation. The interaction between PABP
and eIF4G has been reconstituted using puriﬁed components
(19), and has been demonstrated in yeast (3) and wheat germ
(20) cell-freeextracts.However,directevidencethatthisinter-
action stimulates translation is lacking (21). The essential role
of PABP in mRNA translation has been conﬁrmed recently by
using a PABP depleted cell-free system (22).
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controlling its cellular level may be critical. Available evi-
dence suggests that the cellular level of PABP is regulated in a
developmental or growth-dependent manner at the transla-
tional level. PABP mRNA is a member of the terminal
oligopyrimidine track (TOP) containing mRNA family,
which includes mRNAs that encode components of the protein
synthesizing machinery. The long 50-untranslated region (50-
UTR) of PABP mRNA consists of at least two cis-acting
translation control elements. The ﬁrst control element TOP
at the 50-terminus (23) is followed by a highly conserved A-
rich autoregulatory sequence(ARS) (24).Therole ofthese cis-
acting elements in regulation of PABP expression is well
established but not fully understood. Several mRNAs contain-
ing a 50-TOP sequence exhibit growth dependent translational
control (25,26). Thus, the 50-TOP probably confers regulation
of PABP mRNA translation in a growth-dependent manner to
coordinate expression of components of the protein synthesiz-
ing machinery, whereas the ARS may be involved in constitu-
tive control of the PABP level under all circumstances (23,24).
Results of both in vitro and in vivo studies suggest that the
ARS of PABP mRNA is able to confer autoregulation of
PABP expression by a negative feedback mechanism
(23,24,27). Previous studies have shown that PABP interacts
with the ARS region and addition of puriﬁed PABP to a cell-
free system repressed translation of mRNAs containing the
A-rich sequence in their 50-UTR (25,27). Deletion of the ARS
region from PABP mRNA abolishes its autoregulation,
whereas addition of this region at the 50-UTR of a reporter
gene represses its translation (24). According to the current
understanding, idling PABP represses translation of its own
mRNA by binding to the ARS region, thereby stalling the
movement of the 40S pre-initiation complex within the
50-UTR (28,29). Recent studies have shown that the
C-terminal region of PABP, which is involved in protein–
protein interaction, is necessary for autoregulation of PABP
mRNA translation (15). This implies that interaction between
ARS boundPABP andotherpolypeptides maybe animportant
aspect of translational control.
In the present study we have investigated whether other
polypeptides besides PABP bind to the ARS region. The
results presented here suggest that the ARS region speciﬁcally
interacts with at least three core polypeptides, IMP1, PABP
and UNR, to form a multi subunit autoregulatory ribonucleo-
protein complex (ARC). IMP1 and UNR can bind indepen-
dently to the ARS but their RNA-binding activity was
stimulated by PABP. Therefore, the formation of a het-
eromeric complex may be responsible for the previously
observed stalling of the 40S pre-initiation complex at a site
near the ARS (29).
MATERIALS AND METHODS
Plasmid construction
The 50-UTR region (nt 71–131) of the human PABP cDNA
(GeneBank ID Y00345) corresponding to the ARS was cloned
into appropriate plasmid vectors by using synthetic oligo-
nucleotides. Double-strandedoligodeoxynucleotides encoding
either oligo(A) of different length, wild-type or mutant
ARS sequences were generated by annealing complementary
synthetic oligonucleotide sets (Table 1, only sense sequences
are given). The annealed double-stranded DNA products con-
tained an EcoRI restriction site followed by a T7 RNA poly-
merase promoter sequence at the 50 end, and a BamHI restric-
tion site at the 30 end. The annealed products were digested
with respective restriction enzymes (MBI, Fermentas), puri-
ﬁedfroma2.5%agarosegel usingthe QIAquickgel extraction
kit (Qiagen), cloned into pUC18 (MBI, Fermentas) and
pEGFP-N3 (Clontech, BD Biosciences) plasmid vectors.
For the synthesis of N-terminus 6· His tag epitope contain-
ing protein expression vectors, the IMP1 (GenBank ID:
NM006546), PABP (GeneBank ID: Y00345) and UNR
(GenBank ID: BC032446) cDNAs were ampliﬁed by PCR
using respective pQE-primers sets (Table 2). The forward
and reverse primer contained BamHI and HindIII restriction
sites, respectively. The PCR product was digested with appro-
priate restriction enzymes (MBI, Fermentas), puriﬁed from a
1% agarose gel by QIAquick gel extraction kit (Qiagen), and
cloned into pQE80L (Qiagen) prokaryotic expression vector.
All plasmid constructs were propagated into Escherichia coli
DH5a (Invitrogene) employing standard recombinant tech-
niques (30), isolated using GenElute plasmid maxi-prep kit
(Sigma) and conﬁrmed to be correct by DNA sequencing.
In vitro RNA synthesis
The pUC18 or pEGFP-N3 plasmids containing either oligo(A)
of different length, wild-type or mutant ARS region under the
control of the T7 RNA polymerase sequence were linearized
with BamHI, and pGEM-T vector (Promega) was linearized
with SalI restriction enzyme for in vitro run-off transcription.
Transcription reaction was usually performed at 37 C for 3 h
in a ﬁnal volume of 100 ml containing 10 mg of a DNA tem-
plate, 2.5 mM of each NTP and 100 U of T7 RNA polymerase
(Promega) in the N4 buffer [20 mM MgCl2, 1 mM spermidine,
0.01% Triton X-100, 20 mM DTT and 40 mM Tris–HCl (pH
8.1)]. Uniformly radiolabeled RNA was synthesized under
similar conditions in a ﬁnal reaction volume of 25 ml contain-
ing 150 mCi [a-
32P]ATP (MP Biomedicals) and the ﬁnal con-
centrationofcold ATPreducedto25mmol.Thecontaminating
Table 1. Sense oligonucleotides used to create oligo(A) and various ARS
constructs
Primer Sequence
ARS agaattc gtaatacgactcactataggg aaaaaatccaaaaaaaatctaaaaaaa-
tcttttaaaaaaccccaaaaaaatttacaaaaaa ggatcca
DARS-4 agaattc gtaatacgactcactataggg tccaaaaaaaatctaaaaaaatctttta-
aaaaaccccaaaaaaattt ggatcca
DARS-2L agaattc gtaatacgactcactataggg tccacctctactctactcctatcttttaaa-
aaaccccaaaaaaattt ggatcca
DARS-2R agaattc gtaatacgactcactataggg tccaaaaaaaatctaaaaaaatcttttat-
cctaccccactcctattt ggatcca
DARS-0 agaattc gtaatacgactcactataggg tccacctctactctactcctatctttatcc-
taccccactcctattt ggatcca
LS-ARS agaattc gtaatacgactcactataggg aaaaaaaatctcctcttctccaaaaaaa-
tccctctccctctaaaaaacttccctccctctaaaaaaa ggatcca
Poly(A)50 agaattcgtaatacgactcactatagggaaaaaaaaaaaaaaaaaaaaaaaaaa-
aaaaaaaaaaaaaaaaaaaaaaaaggatcca
Poly(A)20 agaattc gtaatacgactcactataggg aaaaaaaaaaaaaaaaaaaa
ggatcca
Poly(A)13 agaattc gtaatacgactcactataggg aaaaaaaaaaaaa ggatcca
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template were removed by fractionating transcription reaction
mixtures on 8% polyacrylamide gels under denaturing condi-
tions (31). The amount of RNA and its speciﬁc radioactivity
were determined using a spectrophotometer and scintillation
counter, respectively.
Preparation of cytoplasmic extracts
Cytoplasmic protein extracts were prepared as described pre-
viously (32). HeLa, HEK 293, NIH 3T3 and C2 myoblasts
were grown to 90% conﬂuency in DMEM (Sigma) supple-
mented with 10% fetal bovine serum (FBS) and 1% penicillin/
streptomycin (Gibco). Cells were rinsed twice with ice-cold
phosphate-buffered saline (PBS) [137mM NaCl,2.7mM KCl,
10 mM Na2HPO4, 2 mM KH2PO4 (pH 7.4)] and harvested by
scraping in a hypotonic buffer CEB [10 mM HEPES–KOH
(pH 7.5), 3 mM MgCl2, 14 mM KCl, 5% glycerol, 1 mM DTT,
0.02% Igepal CA-630, 0.5 mM phenylmethlysulfonyl ﬂuoride
(PMSF), 10 mg/ml leupeptin and 2 mg/ml aprotinin (Sigma)].
The cells were lysed by repeated passage through a 28-guage
needle, centrifuged for 2 min at 4 C to remove the nuclei and
cell fragments and the supernatants were stored at  85 Ci n
small aliquots. The protein concentration was estimated to be
 20 mg/ml by the BioRad protein assay kit.
Expression and purification of 6· His-tag fusion protein
E.coli DH5a containing the IMP1, PABP or UNR open read-
ing frames cloned into the pQE80L expression vector and
E.coli BL21(DE3) containing pET28b-b-galactosidase plas-
mid were grown to an early log phase and induced for 4 h
with isopropyl-b-D-thiogalactoside. The bacterial cells were
harvested by centrifugation and lysed by incubating with
1 mg/ml of lysozyme in a lysis buffer [50 mM NaH2PO4,
500 mM NaCl, 30 mM imidizole, 13 mM b-mercaptoethanol,
2 mM MgCl2, 1 mM PMSF, 0.5% IgepalCA-630 and 5%
glycerol (pH 8.0)] at 0 C for 30 min. The lysate was cleared
by centrifugation and the supernatant was mixed with Ni-NTA
agarose beads (Qiagen). After shaking at 0 C for 30 min, the
beads were washed extensively with a washing buffer [50 mM
NaH2PO4, 500 mM NaCl, 50 mM imidizole, 13 mM b-
mercaptoethanol, 2 mM MgCl2, 1 mM PMSF, 0.5%
IgepalCA-630 and 5% glycerol (pH 8.0)] and the bound
proteins were eluted in the elution buffer [50 mM
NaH2PO4, 500 mM NaCl, 300 mM imidizole, 13 mM b-
mercaptoethanol, 2 mM MgCl2, 1 mM PMSF, 0.5%
IgepalCA-630 and 5% glycerol (pH 8.0)]. The eluted fraction
was equilibrated with a storage buffer [10 mM HEPES–KOH
(pH7.5),3mMMgCl2,140mMKCl,5%glycerol,1mMDTT,
0.02% Igepal CA-630, 0.5 mM PMSF, 10 mg/ml leupeptin
and 2 mg/ml aprotinin] using the microcon YM-30 concentra-
tion column (Millipore) and stored at  80 C in small aliquots.
For in vivo protein labeling, the E.coli were grown for 24 h
at 37 C in 50 ml of minimal media [6.8 g Na2HPO4, 3.0 g
KH2PO4, 0.5 g NaCl, 1 g NH4Cl, 3 mg CaCl2, 0.25 g
MgSO4.7H2O, 3 g sucrose in one liter H2O (pH 7.4)]. The
cells were collected by centrifugation and resuspended in 1 ml
of the same media supplemented with 1 mCi of Trans [
35S]-
label (MP Biomedicals) metabolic labeling reagent. Protein
expression was induced and proteins were puriﬁed as
described above.
RNA electrophoretic mobility shift assay (REMSA)
REMSA was performed as described previously (32). In short,
20 mg of the cytoplasmic extract was incubated with  1n g
(1 · 10
5 c.p.m.) of radiolabeled RNA for 10 min at 22 Ci na
total reaction volume of 18 ml in the binding buffer [10 mM
HEPES–KOH (pH 7.5), 3 mM MgCl2, 140 mM KCl,
5% glycerol, 1 mM DTT, 0.02% Igepal CA-630, 10 mgo f
E.coli tRNA and 0.02% bromophenol blue]. Subsequently,
heparin was added to a ﬁnal concentration of 10 mg/ml and
incubation was resumed for another 5 min. The sample was
treated with RNase T1 (25 U) for 5 min and analyzed by
electrophoresis in a 2% agarose gel in 0.5· TBE buffer [45
mM Tris–borate, 1 mM EDTA (pH 8.0)], 100 V, at 4 C. The
gel was then vacuum-dried and autoradiographed.
For competition assays, the cell extract was preincubated
with 20–200 ng of an unlabeled RNA for 5 min prior to the
addition of the radiolabeled RNA. For supershift assays, the
cell extract was preincubated with 1 mg of the indicated anti-
body on ice for 10 min prior to the addition of the radiolabeled
RNA. A PABP deﬁcient cell extract was prepared by incubat-
ing 5 ml of the human PABP antibody with 25 ml of HeLa cell
extract at 4 C for 2 h in CEB buffer followed by clearing the
extract through a protein A–Sepharose column (Sigma).
UV crosslinking assay
For UV-induced crosslinking assays, 60 mg of cytoplasmic
extract was incubated with  3n g( 3· 10
5 c.p.m.) of radio-
labeled RNA at 22 C for 10 min in a total reaction volume of
27 ml in the binding buffer. Heparin was added to the ﬁnal
concentration of 10 mg/ml and the sample was irradiated by
UV-light (254 nm, 4000 mw/cm
2)a t4  C for 5 min. The non-
crosslinked RNA was cleaved by RNase T1 (25 U) and RNase
A( 1mg) treatment at 37 C for 5 min. Finally, the sample was
boiled in a protein sample loading buffer [6% glycerol,
2% SDS, 100 mM DTT and 0.02% bromophenol blue in
60 mM Tris–HCl (pH 6.6)] for 5 min and analyzed by 10%
SDS–PAGE. For competition assays, the cell extract was
preincubated with 50–500 ng of an unlabeled RNA for
5 min prior to the addition of the radiolabeled RNA. The
gels were vacuum-dried and autoradiographed.
Isolation of RNA–protein complexes from agarose gels
To isolate the RNA–protein complex, 100 mg of HeLa extract
was incubated with  5n g( 5· 10
5 c.p.m.) of radiolabeled
ARS RNA for 10 min at 22 C in a total reaction volume of
40 ml in the binding buffer. Heparin was added to a ﬁnal
concentration of 10 mg/ml and the sample was irradiated
under UV light for 5 min at 4 C. The ribonucleoprotein
Table 2. Primers used to create Protein expression vectors
Primer Sequence
pQE-IMP1(s) aaaggatccaacaagctttacatcgg
pQE-PABP(s) aaaggatccaaccccagtgccccc
pQE-UNR(s) aaaggatccagctttgatccaaaccttc
pQE-IMP1(as) ctaaagcttcacttcctccgtgcctg
pQE-PABP(as) ctaaagcttaaacagttggaacacc
pQE-UNR(as) ctaaagcttagtcaatgacaccagc
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and visualized by wet gel autoradiography. The gel portion
corresponding to the RNP complex was excised, homogenized
and treated with RNase A (2 mg) and RNase T1 (50 units) for
10 min at 37 C. Finally, the sample was analyzed by 10%
SDS–PAGE followed by autoradiography.
RNA-affinity chromatography
TheARS bindingproteinswere puriﬁedbyRNA-afﬁnitychro-
matography as described previously (33). Fifty micrograms of
in vitro synthesized and gel puriﬁed RNA were oxidized by
sodium periodate (10 mM) in 200 ml of coupling buffer
(100 mM sodium acetate, pH 5.0) at 0 C in the dark for 2
h. The oxidized RNA was precipitated twice with 2.5 vol of
ethanol. Two milliliters (50% slurry) of adipic acid dihy-
drazide agarose beads (Sigma) were equilibrated with the cou-
pling buffer, mixed with the oxidized RNA, and incubated
with gentle shaking at 4 C for 4 h. The unbound RNA was
removed by washing the beads twice with 2 ml of 2 M NaCl
followed by equilibrating the beads with the chromatography
buffer [10 mM HEPES–KOH (pH 7.5), 3mM MgCl2, 140 mM
NaCl, 5% glycerol, 1 mM DTT and 0.01% Triton X-100].
HeLa cell extract (250 ml) was precleared by incubating
with 2 ml (50% slurry) of adipic acid hydrazide agarose
beads in the chromatography buffer in presence of protease
inhibitors (0.5 mM PMSF, 10 mg/ml leupeptin and 2 mg/ml
aprotinin) for 1 h at 4 C. Finally, the RNA conjugated beads
were incubatedwiththepreclearedHeLacellextract at4 Cfor
1h.The unbound proteins were removed by washingthe beads
extensively with the chromatography buffer. The afﬁnity-
bound proteins were eluted by an increasing salt gradient
(0.5, 1.0 and 2.0 M NaCl) in the chromatography buffer.
The eluted protein samples were analyzed by 10% SDS–
PAGE and visualized by silver staining (34).
Peptide analysis
Protein bands from silver nitrate stained gels were excised and
digested in gel with trypsin as described previously (34). The
samples were analyzed by LC/MS/MS using a Thermo Finni-
gan LCQ DECA XP mass spectrometer and the raw mass data
was cross-correlated to a theoretical database using Turbo-
Sequest (Thermo) to identify the proteins.
Transfection of cells
Approximately 3 · 10
5 subconﬂuent HeLa cells grown on a
35 mm dish in DMEM medium with 10% FBS were used for
transfection. Plasmid DNA (1 mg) was incubated with 3 mgo f
LipofectAMINE in 100 ml of Opti-MEM (Invitrogen) for
30 min at25 Cbefore adding tothe cells. Cells were incubated
for 5 h at 37 C with the DNA/liposome mixture in 1 ml of
Opti-MEM. Following the incubation, 1 ml of growth medium
containing 20% FBS was added to the culture. After 12 h of
incubation, the medium was replaced by fresh, complete
DMEM medium (Sigma) containing 10% FBS.
Isolation of RNA and measurement of mRNA levels
The total cellular RNA was isolated using the High Pure RNA
IsolationKit(Roche Biochemical). Thequalityand quantity of
the RNA was determined by 1.5% agarose gel electrophoresis
and spectrophotometry, respectively. The level of a speciﬁc
mRNAinthe sample was determined bycomparative realtime
RT–PCR using Rotor-gene 3000 (Corbett Research, NSW,
Australia) (35). An aliquot of total RNA (1 mg) was reverse
transcribed at 50 C for 1 h in a total reaction volume of 25 ml
by SuperScript II reverse transcriptase and 150 ng random
primers according to manufacturer’s instruction (Invitrogen).
After the reaction, the cDNA sample was ampliﬁed by
PCR with platinum SYBR green qPCR supermix-UDG kit
(Invitrogen) with primers speciﬁc for b-Gal, GFP or b-actin
cDNAs (Table 3). Speciﬁcity of the ampliﬁed PCR products
were examined after the ﬁnal cycle by generating a melting
curve with a heating rate of 1 C/s between 72 and 99 C. The
data were analyzed using Rotor-gene 3000 software with
2
 DDCt method. The relative expression values of b-Gal and
GFP mRNAs were normalized to that of b-actin mRNA.
Measurement of protein levels
Cells were washed twice with PBS and lysed by boiling in
400 ml protein sample loading buffer, 24 h after transfection.
The samples were subjected to 10% SDS–PAGE, and the
separated polypeptides were electrophoretically transferred
to a nitrocellulose membrane for western blotting (30). Mem-
brane was treated with GFP (BD Biosciences) and b-actin
(Sigma) primary antibodies, washed, and further incubation
with the alkaline phosphatase conjugated secondary antibody.
Detection was carried out using the NBT/BCIP reagents and
quantitative analysis was performed using ImageJ (NIH) gel
band densitometry program.
Immunoprecipitation of RNA–protein complex
The in vivo RNA–protein crosslinking and immunoprecipita-
tion assay was performed as described previously (36). HeLa
cells ( 3·10
6 cells) were treated with 1% formaldehyde
(Electron Microscopy Sciences) in PBS for 10 min at room
temperature to crosslink the RNA and proteins of RNP com-
plexes. Following the crosslinking, the cells were lysed in
0.5 ml of RIPA buffer [50 mM Tris–HCl, 1% Igepal CA-
630, 0.5% sodium deoxycholate, 0.05% SDS, 1 mM EDTA,
150 mM NaCl, 0.5 mM PMSF, 10 mg/ml leupeptin, 2 mg/ml
aprotinin,100URNasin(Promega)and100mgofE.colitRNA
(pH7.5)].Antibody(10mg)coated proteinA–Sepharosebeads
(30 ml, packed volume) was incubated with the cell lysate
(250 ml) in RIPA buffer with rotations at room temperature
for 2 h. The beads were washed extensively with high-
stringency RIPA buffer [50 mM Tris–HCl, 1% Igepal CA-
630, 0.1% sodium deoxycholate, 0.1% SDS, 1 mM EDTA,
1MNaCl,2.5MUreaand0.5mMPMSF(pH7.5)].Following
the washing step the RNA–protein crosslink was reversed by
Table 3. Primers used for the real-time RT-PCR
MRNA Nucleotide sequence GenBank ID
Human b-actin (s) ctcttccagccttccttcct (780–799) BC013835
Human b-actin (as) caccttcaccgttccagttt (963–982)
GFP(s) taccagcggtggtttgtttg (4091–4110) U57609
GFP(as) gcagagcgaggtatgtaggc (4252–4271)
b-Gal (s) gctggataacgacattg (2435–2453) U02451
b-Gal (as) cagcaccgcatcagcaag (2560–2577)
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Tris–HCl, 5 mM EDTA, 10 mM DTT and 1% SDS (pH 7.0)].
The sample was extracted once with phenol and once with
chloroform followed by precipitation with ethanol. Contami-
nating DNA in the sample was removed by RQ1 RNase-free
DNase (Promega) treatment and the sample was reverse
transcribed using random primers followed by the PCR amp-
liﬁcation using GFP-speciﬁc primers (sense, 50-ccgtcagatccgc-
tagcgc; antisense, 50-gtcgagctggacggcgac). The samples were
analyzed by electrophoresis in a 2% agarose gel.
RESULTS
Formation of ARS RNA–protein complex
PABP is known to interact with several polypeptides to
accomplish its function in the cell (1–9). We have, therefore,
examinedwhetherPABPcanactasaproteinscaffoldtoforma
multisubunit complex with the ARS region of its mRNA. The
results of crosslinking of the ARS RNA and cellular proteins
from HeLa cells by UV light show that at least four polypep-
tides of Mr 105, 72, 63 and 46 kDa bind to the ARS RNA
(Figure 1A, lane 5). Binding of these polypeptides was not
seen in samples without the UV treatment (Figure 1A, lane 1).
To test the speciﬁcity of this interaction unlabeled competitor
RNAs were used during the UV crosslinking. The results show
that a 100-fold molar excess of unlabeled ARS (Figure 1A,
lane 7) or poly(A)50 RNA (Figure 1A, lane 8) competed efﬁ-
ciently with the [
32P]-labeled ARS RNA for binding to these
polypeptides.Whereas a 100-fold molar excess of an unrelated
RNA of size similar to the ARS RNA derived from the tran-
scription of an empty pGEM-T plasmid vector (Promega) was
unable to compete with the [
32P]-labeled ARS RNA for bind-
ing to all four polypeptides (Figure 1A, lane 6). To further
examine whether the ARS binding polypeptides are also pre-
sent in different cell types, UV crosslinking experiments were
performed using mouse NIH3T3 and C2 cells, and human
HEK293 cells. The results (Figure 1A, lanes 2–4) show that
similar polypeptides could be seen in all four crosslinking
experiments.
To further examine the ARS RNP complex, we used RNA
gel shift analyses. The results show that one major (ARC) and
one minor RNP complex are formed with all four cell extracts
tested (Figure 1B, lanes 2–5). The electrophoretic mobility
shift of the [
32P]ARS RNA was inhibited by unlabeled
ARS (Figure 1B, lane 7) or poly(A)50 RNA (Figure 1B,
lane 8) while the unrelated pGEM-T empty vector derived
RNA failedtocompete (Figure 1B, lane 6).TheARC migrated
considerably slower in the gel compared with the RNP com-
plex formed by incubating ARS-RNA with puriﬁed PABP
(Figure 1B, lane 11), which suggests that the ARC is a het-
eromeric complex. Further analyses using HeLa cell extracts
show that formation of the ARC can be inhibited by depleting
PABP from the extract with PABP antibody (Figure 1B,
lane 9) but not by a GFP antibody (Figure 1B, lane 10).
These results suggest that PABP plays an essential role
in the formation of the heteromeric ARS-RNA–protein
complex.
As more than one polypeptide may be present in the RNP
complex formed between the cellular proteins and the ARS
RNA, we analyzed the polypeptide complements of this
complex. The UV irradiated RNP complexes were resolved
and extracted froman agarose gel andthe presence ofpolypep-
tides bound to the ARS RNA was analyzed by SDS–PAGE
(Figure 1C). The results show that three polypeptides of
Mr 105, 72 and 63 kDa were present in the slower migrating
major complex (Figure 1C, lane 2). The faster migratingminor
complex consisted of two of these three polypeptides which
included the 72 and 63 kDa polypeptides (Figure 1C, lane 3).
These results suggest that a multimeric complex consisting of
three different polypeptides can be formed with the ARS. It is
not certain whether the minor complex was the dissociation
product of the larger complex or represents an intermediate
complex. Therefore, we investigated this possibility by ana-
lyzingthe formationofthesecomplexesatdifferent incubation
times. The results (not shown here) did not show any changes
in the relative ratios between the two complexes. Therefore,
the minor complex is likely a dissociation product of the
ARC, which implies that the 105 kDa polypeptide was less
tightly bound to the ARS RNA than the 72 and the 63 kDa
polypeptides.
The ability of ARS to form homo-oligimeric complexes
with puriﬁed PABP was further investigated by gel shift
assays. The results show that in the presence of a limiting
amount of PABP, ARS formed a monomeric complex
(Figure 2A, lanes 2–5) whereas the poly(A)50 RNA, which
has approximately the same number of adenines as the ARS,
under similar conditions formed predominantly a monomeric
complex, but also formed signiﬁcant levels of both dimeric
and trimeric complexes (Figure 2A, lanes 6–9). Also, as
judged by the amount of radioactivity present in the RNP
complex, PABP bound to poly(A)50, almost two times more
efﬁciently than what was observed with the ARS RNA at all
protein concentrations tested. RNAs with shorter stretches of
adenine residues including poly(A)20 and poly(A)13 did not
bind to PABP efﬁciently and could not form detectable levels
of dimeric and trimeric complexes (Figure 2A, lanes 10–13
and lanes 14–17, respectively). In a previous study formation
of both dimeric and trimeric complexes with the ARS was
reported (15). However, in these studies PABP was present in
several fold molar excess to that of the ARS RNA; under these
conditions the formation of oligomeric RNP complex through
PABP–PABP interaction may be facilitated. Nevertheless, this
group also reported formation of a predominantly monomeric
ARS RNA–PABP complex [Ref. (15), Figure 4B, lanes with
3.8 ng PABP] at a lower PABP concentration. Results of our
studies, therefore, suggest that the slower migrating RNP com-
plex of the ARS seen with the total HeLa cell extract consists
of more than one polypeptide. This complex may more
efﬁciently repress mRNA translation than PABP alone
which predominantly forms a monomeric complex with the
ARS RNA.
Inadditiontothe gel shift assays,we comparedthe abilityof
the ARS and poly(A)50 RNA to bind to PABP by UV
crosslinking studies. The results show that under similar con-
ditions poly(A)50 (Figure 2B) binds to PABP almost two times
more efﬁciently than the ARS (Figure 2C). This was also
evident in competition studies, as  2-fold more unlabeled
ARS (Figure 2C, lanes 3–8 and triangles in Figure 2D) was
required than that of the unlabeled poly(A)50 RNA (Figure 2C,
lanes 9–14 and legend crosses in Figure 2D) to attain a similar
level of inhibition of the binding of radioactively labeled ARS
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radioactively labeled poly(A)50 to PABP also show that the
poly(A)50 binds more tightly to PABP than the ARS, as
more unlabeled poly(A)50 RNA (Figure 2D, legend circles or
squares, respectively) was required for this competition, than
what was necessary to obtain a similar level of competition
with the radio labeledARS RNA (Figure 2D, legend crosses or
triangles, respectively). Also, in these binding studies using
Figure1.FormationofARSRNA–proteincomplex.(A)RNA–proteincrosslinkingbyUV.Theinvitrosynthesized[
32P]-labeledARSRNA( 3ng,3 · 10
5c.p.m.)
was incubatedwith different cell extract ( 60 mg protein)in the flat capof a 0.2 ml PCR tube.Followingthe UV treatment,the samples were treated with RNaseA/
RNase T1, analyzed by 10% SDS–PAGE and autoradiographed as described under experimental procedures.Cell extracts from mouse NIH3T3 fibroblasts(lane 2)
and C2 myoblasts (lane 3), and human HEK293 (lane 4) and HeLa cells (lane 5) were used for these studies. One sample containing HeLa cell extract (lane 1) was
analyzed without UV treatment as a control. Approximately 300 ng of the non-radioactive pGEM-T (lane 6), ARS (lane 7) or poly(A)50 RNA (lane 8) was used
for competition studies. (B) Analysis of RNP complex by REMSA. The in vitro synthesized [
32P]-labeled ARS RNA ( 1 ng, 1 · 10
5 c.p.m.) was incubated with
different cell extracts (20 mg) as indicated above each lane. The unbound RNA was digested with RNaseT1 and subjected to electrophoresis in a 2% agarose as
describedintheexperimentalprocedures.Lane1,radioactiveARSRNAincubatedwithoutthecellextract;lanes2–5,radioactiveARSRNAincubatedwithNIH3T3,
C2, HEK293 and HeLa cell extracts, respectively. Lanes 6–8, competition with 100 ng of non-radioactive pGEM-T, ARS, or poly(A)50 RNA, respectively. Lane 9,
cellextractwaspre-incubatedwiththePABPantibodyandpreclearedwithproteinA-sepharosebeadsbeforebeingusedforREMSA.Approximately20mgofPABP
deficientcellextractwasusedforREMSA.Lane10,cellextractwassimilarlytreatedwiththeGFPantibody(BDBiosciences)beforebeingusedforREMSA.Lane
11,radiolabeledARSRNA( 1ng,1 · 10
5c.p.m.)incubatedwith 2ngofpurified6·His-PABP.(C)AnalysisofRNPcomplexesbySDS–PAGE.RNPcomplex
formationwasinitiatedasdescribedaboveandthesampleswereirradiatedbyUVbeforebeingresolvedina2%agarosegel.TheRNPbands(asshowninFigure1B)
wereexcisedfromthegel,treatedwithRNaseA/RNaseT1,andanalyzedby10%SDS–PAGEasdescribedintheMaterialsandMethods.Lane1,ARSRNAandHeLa
extractstreatedwithUVandanalyzedbeforegelpurification.Lane2,polypeptidesfromthegelpurifiedslowermigratingARC.Lane3,polypeptidesfromthefaster
migrating minor complex.
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ciently than the unlabeled poly(A)50.
Identification of polypeptides of the ARC
To identify the polypeptides of the ARC, we puriﬁed the ARS
binding polypeptides by RNA-afﬁnity chromatography
(Figure 3). The results show that several polypeptides
bind tightly to the ARS RNA (Figure 3, lane 2). Control
experiments using the pGEM-T vector derived RNA ligand
in afﬁnity chromatography show that several of these polypep-
tides are probably non-speciﬁc RNA-binding proteins
(Figure 3, lane 1). The polypeptides that are unique to the
ARS RNA afﬁnity chromatography are marked by arrows.
A total of 14 ARS RNA speciﬁc polypeptides including the
105, 72, 63 and 46 kDa polypeptides that were seen in the gel
puriﬁed ARC or UV crosslinking studies can be seen in the
afﬁnity puriﬁed material. As 10 of these polypeptides were not
Figure 2. Comparison of the ability of the ARS and poly(A) RNA to bind PABP. (A) Gel-shift assays of binding of PABP to the ARS and poly(A) RNAs of
variouslength.REMSAwasperformedusing0.2,0.4,0.8and1.6ngofpurified6·His-PABPand 1.5ngof[
32P]-labeledARS(lanes2–5),poly(A)50(lanes6–9),
poly(A)20 (lanes 10–13) and poly(A)13 (lanes 14–17) RNAs. Samples were analyzed on 5% PAGE under non-denaturing conditions. (B and C) UV crosslinking
assaysofbindingofPABPto ARSandpoly(A)50RNAs.Thein vitrosynthesized[
32P]-labeledARSandpoly(A)50 RNAs( 3 ng,3 · 10
5) wereincubatedwiththe
purified PABP ( 2 ng) for 5 min at room temperature. Unlabeled ARS (lanes 3–8) or poly(A)50 (lanes 9–14) competitor RNAs were added (10-fold molar excess
increment)andincubatedfurtherattheroomtemperaturefor3min.FollowingtheUVtreatment,thesamplesweretreatedwithRNaseA/RNaseT1,fractionatedona
10%SDS–PAGEandvisualizedbyautoradiography.Lane1,sampleswithoutUVtreatment;lane2,sampleswithoutunlabeledcompetitorRNA.(D)TheRNPbands
in(AandB)wereexcisedbysuperimposingtheradiographandthelevelofradioactivitywasmeasuredbyscintillationcounter.Theaveragelevelofradioactivityof
the RNP complex in each band from three separate competition experiments was plotted against the molar concentration of the competitor RNA.
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not authentic partners of the ARS-RNA. However, it is pos-
sible that these polypeptides bind to the ARS RNA through
protein–protein interactions. Since visualization of the
polypeptides in the gel puriﬁed ARC or in the UV crosslinking
samples depends on the presence of small fragments of cova-
lently linked [
32P]-labeled RNA, this method may exclude
polypeptides that are present in the RNP complex through
their direct interaction with RNA-binding proteins. The afﬁn-
ity puriﬁed 72 kDa polypeptide was less abundant in the 2 M
NaCl eluted fraction than other polypeptides. This was prim-
arily due to the tight binding of the 72 kDa (PABP) to the ARS
RNA. This polypeptide was present in relatively large quan-
tities in the SDS eluted fraction (result not shown).
Among the 14 polypeptides binding speciﬁcally to the ARS
RNA containing matrix we analyzed the 105, 72, 63 and 46
kDapolypeptidesbymassspectrometryoftrypticdigestssince
these were the only polypeptides that showed binding to the
ARS RNA in UV crosslinking studies. The results of LC/MS/
MS analyses are summarized in Table 4. As expected, the 72
kDa polypeptide was identiﬁed as PABP. The 63 kDa poly-
peptide is a known RNA-binding protein IMP1 and the 105
kDa polypeptide was identiﬁed as UNR, a known PABP inter-
acting protein. The 46 kDa polypeptide was identiﬁed as
b-actin. As b-actin and 11 other polypeptides were not present
in the gel puriﬁed RNP complex, we considered them not to be
the parts of a stable core complex and did not pursue inves-
tigating these polypeptides further.
To determine whether PABP, IMP and UNR polypeptides
are present in the ARS-RNA protein complex, we tested the
ability of PABP, IMP1 and UNR antibodies to bind to the
ARC. The results of REMSA super-shift analyses show that
both IMP1 and UNR antibodies were able to super-shift the
ARC (Figure 4A, lanes 4 and 6). Both antibodies behaved
similarly to that of the PABP antibody (Figure 4A, lane 5).
The non-immunized serum was ineffective in the super-shift
assay (Figure 4A, lane 3).
We further tested the ability of IMP1 and UNR to directly
interact with the ARS RNA in in vitro binding assays. The 6·
His-tagged PABP, IMP1 and UNR were labeled with [
35S]
during expression in E.coli and puriﬁed by Ni-NTA afﬁnity
chromatography. The ability of puriﬁed radiolabeled proteins
to bind ARS-RNA conjugated agarose beads was tested as
described previously (11). The results show that PABP
binds to the ARS-agarose beads efﬁciently and this binding
was resistant to 0.5 M NaCl treatment (Figure 4B and C,
lane 2). IMP1 alone was also able to bind to ARS-agarose
beads almost as efﬁciently as PABP at physiological salt con-
centration (Figure 4B, lane 5), but this binding was sensitive to
0.5 M NaCl, as very little binding of IMP1 to ARS-agarose
beads at this salt concentration was observed (Figure 4B,
lane 3). UNR alone on the other hand showed a considerable
lower binding ability to the ARS-agarose beads than that of
either PABP or IMP1 at physiological salt concentration
(Figure 4C, lane 5). As controls, we used [
35S]-labeled total
cell extract from non-transformed E.coli (Figure 4B and C,
lane 1), in vitro translated [
35S]methionine labeled luciferase
(Figure 4B and B, lane 9) and puriﬁed [
35S]-labeled 6· His-
tagged b-galactosidase (Figure 4B and C, lane 10). No
detectable binding of these polypeptides to the ARS-agarose
beads was observed, which suggests that non-speciﬁc binding
of polypeptides to the RNA was minimal under our experi-
mental conditions. Therefore, the results of these binding
Table 4. Identity of polypeptides binding to the ARS-RNA by LC/MS/MS
MW (kDa) Peptide sequence Peptide ID Homologs References
105 ATNIEVLSNTFQFTNEAR
DQFGFINYEVGDSKK
LLGYVATLK IKVDFVIPK EAFGFIER
UNR KIAA0885, D3Jfr1, NRAS, mKIAA0885, D1S155E (46,47)
72 SLGYAYVNFQQPADAER
EAAQKAVNSATGVPTV
ALYDTFSAFGNILSCK GFGFVCFSSPEEATK
GYGFVHFETQEAAER
PABP PABP1, PAB1, PABPC1 (47)
65 VNELQNLTAAEVVVPR ISYSGQFLVK
RLEIEHSVPK QQQVDIPLR
IMP1 MGC68429, Zipcode-binding protien (37–40,48)
Figure 3. Affinity chromatography of ARS RNA-binding proteins. In vitro
synthesized ARS RNA was covalently linked to agarose beads and incubated
with HeLa cell extract. The bound polypeptides were eluted, resolved on 10%
SDS–PAGEandvisualizedbysilverstaining.Lane1,pGEM-Tandlane2,ARS
RNA bound protein fractions. The polypeptides specific for the ARS RNA
affinity chromatography are shown by arrows. The polypeptides with bold
arrows were seen in the UV crosslinking experiments.
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dently to the ARS RNA, albeit, with lower afﬁnity than PABP.
Similar pull-down studies with poly(A)50–agarose beads did
not show detectable binding to IMP1 (Figure 4B, lane 11) and
UNR (Figure 4C, lane 11). Thus, a stretch of 50 adenine
residues alone is not sufﬁcient for binding IMP1 and UNR,
the pyrimidine bases that separate the A-rich regions of the
ARS must be present to form the correct binding site.
There is an apparent contradiction between the inability of
IMP1 and UNR to bind to the poly(A)50–agarose beads
(Figure 4B and C, lane 11) and the results of UV crosslinking
studies (Figure 1A) which showed that poly(A)50 RNA com-
peted with the binding of both 63 (IMP1) and 105 (UNR) kDa
polypeptides to the labeled ARS RNA. A possible interpreta-
tion of this difference is that both IMP1 and UNR can make
contact withthe poly(A)50inpresence ofPABP inthe totalcell
extract,andtherefore,cancompetewiththeARSwhenpresent
in several fold molar excess. However, this interaction is weak
in absence of PABP; therefore, both proteins were removed
from the poly(A)50–agarose beads during the washing
Figure 4. InteractionofIMP1andUNRwithRNA.(A)PresenceofIMP1,PABPandUNRintheARSRNA–proteincomplex.REMSAwasperformedusing[
32P]-
labeledARSRNAandHeLacellextractasdescribed.Cellextract( 20mg)wasincubatedwith 1mgofeithernon-immunizedserum(lane3),IMP1(lane4),PABP
(lane5)orUNR(lane6)antibodyfor10minonicepriortotheadditionofthelabeledARSRNA( 1ng,1 · 10
5c.p.m.).Samplesweresubjectedto5%PAGEunder
non-denaturingconditions.(B)BindingofIMP1totheARSRNA.[
35S]methioninelabeled6·His-taggedIMP1,PABP,UNRandb-galactosidasewereexpressedin
E.coliandpurifiedbyNi-NTAagaroseasdescribedinMaterialsandMethods.ThepurifiedpolypeptideswereincubatedwithARSorpoly(A)50–agarosebeadsand
the bound proteins were eluted by boiling the beads in protein sample loading buffer and analyzed by 10% SDS–PAGE. In some binding reactions the indicated
amount of purified non-radiolabeled PABP was added. Lane 1, [
35S]methionine labeled total cell extract from non-transformed E.coli DH5a; Lane 2, [
35S]methio-
nine labeled PABP; Lanes 3–5, [
35S]methionine labeled IMP1 at different NaCl concentration; Lanes 6–8, [
35S]methionine labeled IMP1 and indicated amount of
unlabeledPABP.Lane9,[
35S]methioninelabeledLuciferase.Lane10,[
35S]methioninelabeledHis-taggedb-galactosidase.Lane11,bindingofIMP1topoly(A)50–
agarose. (C) Binding of UNR to the ARS RNA. Experiment was performed under similar conditions as in (B). Lanes 1, 2, 9 and 10 are same as in (A); Lanes 3–5,
[
35S]methioninelabeledUNRatdifferentNaClconcentration;Lane6–8,[
35S]methioninelabeledUNRandindicatedamountofunlabeledPABP.Lane11,binding
of UNR to poly(A)50–agarose.
7082 Nucleic Acids Research, 2005, Vol. 33, No. 22procedure. TheinabilityofUNR tobindpoly(A)RNA hasalso
been reported earlier (8).
We also tested whether PABP facilitates the binding of
IMP1 and UNR to the ARS RNA. The results show that
the presence of unlabeled PABP during the binding reaction
stimulated binding of both IMP1 and UNR to the ARS-agarose
beads in a dose-dependent manner (Figure 4B and C,
lanes 6–8). Maximum stimulation of binding to ARS-agarose
was observed when  4-fold molar excess of PABP was used
(Figure 4B and C, lane 7). In the presence of PABP the binding
ability of IMP1 and UNR to ARS RNA was similar since
PABP had a greater stimulatory effect on the binding of
UNR to the ARS RNA than that of the IMP1. PABP also
stimulated binding of IMP1 and UNR to the ARS RNA at
0.5 M NaCl concentration (data not shown). Results of both
gel supershift assays and in vitro RNA–protein binding stud-
ies, therefore, suggest that IMP1 and UNR are legitimate part-
ners of the ARC, and PABP stabilizes their interaction with
the ARS.
Formation of ARC and translational repression
To obtain insights into the role of ARC formation in repressing
PABPmRNA translation, theeffectofvarious mutationsinthe
ARS region on the RNP complex formation and its ability to
repress mRNA translation was examined. Altogether ﬁve
mutant RNAs were used in our studies (Figure 5A). The
authentic ARS region of human PABP mRNA contains six
oligo(A) rich regions which are separated by 3–6 pyrimidine
bases. The ﬁrst mutant RNA tested for RNP formation by
REMSA had four internal oligo(A) rich regions, one oligo(A)
containing region from both the 50 and the 30 ends were
deleted. This shorter ARS RNA (DARS-4) formed the same
RNP complex (Figure 5B, lane 3) as the wild-type ARS region
(Figure 5B, lane 2). Two additional mutant RNAs which had
only the two oligo(A) regions at either the 50 end (DARS-2L)
or the 30 end (DARS-2R) were unable to form the RNP com-
plex similar to the wild-type RNA (Figure 5B, lanes 4 and 5,
respectively). For both mutant RNAs, a low level of a slower
migrating complex than the ARC was observed. This complex
most likely contained different polypeptides than those found
in the ARC since its formation was not competed by unlabeled
wild-type ARS RNA (Figure 5B, lanes 10 and 11, respec-
tively). Deletion of all six oligo(A)s from the ARS RNA
and replacing them with mostly pyrimidine bases (DARS-0)
also prevented ARC formation (Figure 5B: lane 6). The
DARS-0 RNA formed two faster migrating complexes than
the ARC. As formation of these two complexes was also not
inhibited by unlabeled ARS RNA (Figure 5B, lane 12), it is
unlikely that they shared any polypeptides with the ARC. We
also tested another mutant ARS RNA which had all six oli-
go(A) regions but the spacings between them were uniformly
Figure 5. The ability of different mutant ARS RNAs to form the ARC. (A) Wild-type and various mutants ARS RNA sequences. (B)[
32P]-labeled wild-type or
mutantARSRNAs(A)werepreparedasdescribedandusedinREMSA.Forcompetition, 20-foldmolarexcessofunlabeledARSRNAwasaddedtothecellextract
prior to the addition of the radiolabeled RNA ( 1 ng). The samples were treated with RNase T1 and analyzed by electrophoresis on a 2% agarose gel. (C) Mutant
ARS-protein crosslinking by UV. Approximately 3 ng of [
32P]-labeled mutant ARS RNA (A) was incubated with the HeLa cell extract ( 60 mg) in the flat cap of a
0.2 ml PCR tube. Following the UV treatment, the samples were treated with RNaseT1/RNaseA, analyzed by 10% SDS–PAGE and autoradiographed as described
under Materials and Methods.
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failed to form the ARC, instead it formed a signiﬁcant level
of a much faster migrating complex (Figure 5B: lane 7). Again
formation of this faster migrating complex was not inhibited
by unlabeled ARS RNA (Figure 5B: lane 13), therefore, sug-
gesting that this complex did not share any polypeptides with
the ARC. The results of RNP formation by different mutant
RNAs suggest that binding of IMP1, PABP and UNR to the
ARS to form the ARC requires the presence of at least four
stretches of oligo(A)s and also an appropriate length of spacer
sequences betweenthem,which isprobablybetween3and6nt
inlength. Thespacer lengthof13ntusedinourstudieswas not
suitable for ARC formation.
We also used these mutant ARS RNAs in UV crosslinking
assays to detect the nature of bound polypeptides (Figure 5C).
The DARS-4 showed binding to 105, 72, 63 and 46 kDa
polypeptides (Figure 5C: lane 1) as seen previously with
the wild-type ARS RNA (Figure 1A). However, mutant
ARS RNAs withfewer oligo(A) stretches and increased spacer
lengths between the oligo(A)s did not bind to these polypep-
tides (Figure 5C, lanes 2–5). As the ability of mutated ARS
RNA to bind 63 (IMP1), 72 (PABP) and 105 (UNR) kDa
polypeptides were affected simultaneously it is likely that
all three polypeptides bind to the ARS as a multimeric protein
complex. These results also suggest that the IMP1 and UNR
binding site are present within the 47 nt-long region of the
DARS-4 RNA. Since poly(A)50 can not bind IMP1 and UNR
(Figure 4B and C, lane 11), the conserved pyrimidine stretches
between the oliog(A)s of the DARS-4 RNA are necessary to
form the IMP1 and UNR binding site.
The physiological signiﬁcance of RNP formation was
examined by using expression of the normal or the mutant
ARS containing GFP reporter gene. In all cases the mutant or
the normal ARS sequences (Figure 5A) were placed at the 50-
UTR of the GFP reporter gene derived from the pEGFP-N3
expression vector (Figure 6A). Analyses of the GFP polypep-
tide levels in transiently transfected HeLa cells by western
blotting show that the ARS (Figure 6B, lane 1) or the
DARS-4 (Figure 6B, lane 2) containing constructs did
not express high levels of GFP. In contrast, replacing the
wild-type ARS by one of the mutant ARS represented
either by DARS-2L, DARS-2R, DARS-0 or LS-ARS in our
Figure 6. GFP expression from wild-type and mutant ARS containing reporter genes. Cells were transfected with various GFP reporter constructs (pEGFP-N3)
containing either poly(A)of different length, wild-typeor mutant ARS regions in the 50-UTR. To evaluate the transfection efficiency cells were also co-transfected
withanunmodifiedpEGFP-C1plasmid,whichencodesalargerGFPthanthepEGFP-N3.ThecellularlevelsofGFP-N3,GFP-C1(transfectioncontrol)andb-actin
(loading control) polypeptides were measured by western blotting. The results presented here are representative of five separate transfection experiments.
(A) pEGFP-N3 plasmid constructs containing wild-type or mutant ARS region. (B and C) Western blots, the numbers at the bottom within parentheses show
the relative levels of GFP-N3 after correcting for the variations in the loading and transfection efficiency.
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expression level in DARS-2L (Figure 6B, lane 3) and DARS-
2R (Figure 6, lane 4) containing transcripts were similar to
whatwas observed in cells transfected with the parent GFP-N3
construct lacking the ARS (Figure 6B: lane 7). The GFP level
in cells transfected with DARS-0 and LS-ARS (Figure 6B,
lanes 5 and 6, respectively) was a little higher than that of
the control cells (GFP-N3, Figure 6B, lane 7). This increase
was probably due to insertion of pyrimidine nucleotides in the
ARS. As transfection efﬁciency controls we co-transfected
cells with a GFP construct that lacked the ARS and produced
a slightly longer protein owing to translation of the sequences
within the multiple cloning site (pEGFP-C1, Clontech).
Almost equal levels of this longer GFP-C1 were produced
in cells transfected with the different reporter constructs.
The GFP-N3 levels in all experiments were corrected for dif-
ferences in loading and transfection efﬁciencies using b-actin
and GFP-C1 levels, respectively.
Additional transfection studies using constructs expressing
the reporter GFP mRNA with either a poly(A)13, poly(A)20 or
a poly(A)50 containing region at its 50-UTR were performed to
correlate the translational repression by the ARS and poly(A)
tracts of different length. The results (Figure 6C) show that the
GFPlevel incells expressing poly(A)13(Figure 6C,lane3)and
poly(A)20 (Figure 6C, lane 4) containing mRNA was almost
50% less than the control GFP-N3 mRNA expressing cells
(Figure 6C, lane 2). Almost 90% reduction of GFP level was
observed in cells expressing poly(A)50 containing reporter
mRNA (Figure 6C, lane 5). The presence of full-length
ARS at the 50-UTR was, however, signiﬁcantly more effective
than the poly(A)50 in preventing GFP expression (Figure 6C,
lane 6).
We then determined whether the reporter mRNA levels in
cells transfected with different ARS containing constructs
were similar. In earlier studies, we showed that presence of
the ARS in the 50-UTR of a reporter b-gal mRNA repressed its
translation (24). In these studies we observed that the same
level of the reporter mRNA can be detected by real-time RT–
PCR (Figure 7A). As internal controls to monitor the trans-
fection efﬁciencies the cells were co-transfected with a
pCMV-SPORT-b-gal plasmid (Invitrogen). The GFP
mRNA levels were normalized by the level of the b-gal
mRNA. Since earlier studies (24,29) using the sucrose density
gradient proﬁle of the ARS containing reporter mRNA had
established that the translation of the reporter mRNA is
repressed by the ARS, we did not perform similar sucrose
gradient analyses of the mutant ARS containing transcripts.
The results of analysis of the mRNA levels show that similar
levels of GFP mRNA were present in cells transfected with
different constructs.
Taken together the results of GFP protein level and mRNA
level measurements strongly suggest that while the ARS or
DARS-4 containing mRNAs were translationally repressed,
the mRNAs containing the mutated DARS-0, LS-ARS,
DARS-2L and DARS-2R were not repressed. Thus, there is
good correlation between the inability of the mutant ARS to
form the ARC and repress mRNA translation. Also the
result of GFP polypeptide and mRNA levels in cells express-
ing poly(A)13, poly(A)20 and poly(A)50 containing mRNAs
suggest a direct relationship of the length of the poly(A)
tract with the formation of multimeric complexes, and ability
to repress translation when placed at the 50-UTR of a reporter
mRNA.
Ribonucleoprotein immunoprecipitation (RIP) assays (36)
were performed to determine if IMP1 and UNR bind to the
ARS region of the reporter GFP mRNA in vivo. HeLa cells
were transfected with either the wild-type or the ARS con-
taining pEGFP-N3 reporter construct (Figure 7B), and 24 h
after transfection, the RNA–protein interaction was stabilized
in situ by formaldehyde treatment. The RNP complex was
immunoprecipitated using speciﬁc antibodies and the presence
of GFP reporter mRNA in the sample was analyzed using RT–
PCR. The results of RIP assay (Figure 7C) show that the ARS
containing GFP reporter mRNA was speciﬁcally precipitated
by the IMP1 (Figure 7C, lane 2) and UNR (Figure 7C, lane 3)
antibodies, whereas the same antibodies failed to precipitate
the wild-type GFP reporter mRNA that did not contain ARS
(Figure 7C, lanes 8 and 9, respectively). The PCR analyses of
samples without reverse transcription (Figure 7C, lanes 5
and 6) or RT–PCR analysis of samples treated with RNase
(results not shown) revealed no ampliﬁcation of the target
RNA sequence. Also, the presence of GFP reporter mRNA
was not detected in samples immunoprecipitated using rabbit
pre-serum (Figure 7C, Lanes 4, 7 and 10). Thus, the results
show that IMP1 and UNR can bind speciﬁcally to the ARS and
not to any other region in the GFP mRNA in vivo.
DISCUSSION
PABP mRNA translation is autoregulated by an A-rich cis
element at its 50-UTR. We have shown earlier that the ARS
binds to PABP and can repress translation of a reporter mRNA
(24,27). Although presence of a short, 10–60 nt long poly(A)
sequence at the 50-UTR of a reporter mRNA can also inhibit
translation (15,37), the precise mechanism how ARS and
poly(A) sequence inhibits translation could differ. Result of
our studies suggests that, indeed, this is the case. We showed
that the ARS is almost three times more effective than the
poly(A)50 in repressing mRNA translation (Figure 6C). This
difference is probably due to the greater ability of the ARS to
form a trimeric RNP complex with IMP1, PABP and UNR
than what was observed for the poly(A)50. We have shown that
the poly(A)50 can not bind to IMP1 and UNR, and forms
largely a monomeric and a small amount of dimeric and tri-
meric complexes with PABP at a limiting concentration of this
polypeptide. A previous study (37) has shown that a stretch of
as few as 10 adenines at the 50-UTR of an mRNA can repress
translation as efﬁciently as the ARS in H293 cells. The reasons
for this difference in results between the two studies are not
known. However, the use of different cell-lines and promoters
for reporter mRNA expression in these two studies could be a
contributing factor. Furthermore, an earlier report suggested
that H293 cells are refractory to the ARS mediated repression
of PABP mRNA translation and a region near the initiation
codon of PABP mRNA have the ability to override ARS
mediated repression (23). In this context it is noteworthy,
that in UV crosslinking studies signiﬁcantly more ARS
bound 63 kDa polypeptide (IMP1) was observed with HeLa
cell extract than what were seen with H293, 3T3 and C2 cell
extracts (Figure 1A). Therefore, the greater availability of
Nucleic Acids Research, 2005, Vol. 33, No. 22 7085IMP1 to bind to the ARS in HeLa cells could enhance the
ability of ARS to repress translation in these cells.
We have shown earlier that the ARS prevents mRNA trans-
lationbystalling the 40S ribosomalsubunitatasite adjacent to
the ARS (29). It is likely that the critical factor in determining
the ability of ARS to repress translation is the formation of a
multisubunit RNP complex, sufﬁciently large, to prevent the
scanning 40S ribosomal subunits from reaching the initiation
codon. It is possible that at a sufﬁciently high cellular PABP
level a homotrimeric complex between PABP and the ARS
could form (15). However, this process would allow more
PABP synthesis before the repression mechanism is triggered,
than, if a multimeric complex with additional proteins is
formed.
Survey of the 50-UTR region of PABP mRNA from differ-
ent species revealed that not only the presence of the A-rich
region is highly conserved but also the sequence of the
pyrimidine rich spacers between the oligo(A) regions is con-
served between several species (Table 5). Therefore, it is not
surprising that the conserved pyrimidine rich regions of the
ARS are also requiredfor binding toadditional polypeptides to
repress PABP mRNA translation. In these studies we have
shown that two additional polypeptides of 63 and 105 kDa
can be crosslinked to the ARS RNA in vitro by UV. These two
Table 5. ARS sequence homology among different species
Organisms ARS sequence
Homo Sapiens aaaaaaa tcc aaaaaaaa tct aaaaaaa tctttt aaaaaa cccc
aaaaaaa tttac aaaaaa
Pleioblastus Pygmaeus aaaaaa tcc aaaaaaaa tct aaaaaaa tctttt aaaaaa cccc
aaaaaaa tttac aaaaaaa
Mus Musculus aaaaaa tcc aaaaaaaa tct aaaaaat cctttg aaaaaa accc
aaaaaaa tttac aaaaaaa
Rattus Norvegicus aaaaaa tcc aaaaaaaa tct aaaaaat cctttg aaaaaa accc
aaaaaaa tttac aaaaaa
Xenopus Laevis aaaaa tcc aaaaaaaa tct aaaaaat cctttg aaaaaa ccca
aaaaaaa tttac aaaaaaa
Figure 7. Analysis of the reporter mRNA. (A) Measurement of mRNA levels by real-time RT–PCR. HeLa cells were transfected with various GFP reporter
constructs to express GFP mRNA containing either poly(A) of different length, wild-type or mutant ARS elements in their 50-UTR. Cells were co-transfected with
pCMV-SPORT-b-galvectorasacontrolforthetransfectionefficiencybetweenexperiments.TotalcellularRNAfromthetransfectedcellswasanalyzedbyreal-time
RT–PCR using gene specific primers (Table 3) as described in Materials and Methods. Two separate analyses for each of the four independent transfection
experimentswere performedand averagesof eight measurements are presented here.The b-actin mRNAlevel wasmeasured asan internal loadingcontrol.PCR of
RNA from the ARS-pEGFP-N3 transfected cells was carried out without performing the reverse transcription step as a negative control. (B) In vivo RNA–protein
crosslinkingandimmunoprecipitation.InvivocrosslinkedRNPswereimmunoprecipitatedusingIMP1andUNRantibodies.ThepresenceofGFPreportermRNAin
the immunoprecipitae was analyzed by RT–PCR. Samples without the reverse transcription step (RT-) were also used in PCRs to monitor the absence of any
contaminating plasmid DNA. Lane 1, DNA marker; lanes 2–4, RT–PCR analysis of ARS
+-GFP samples immunoprecipitated using IMP1, UNR, and rabbit pre-
serum, respectively. Lanes 5–7, analysis of ARS
+-GFP samples immunoprecipitated using IMP1, UNR and rabbit pre-serum without RT reaction, respectively.
Lanes 8–10, RT–PCR analysis of ARS
 -GFP samples immunoprecipitated using IMP1, UNR and rabbit pre-serum, respectively.
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identiﬁed by mass spectrometry as IMP1 and UNR, respec-
tively. We have further shown that both IMP1 and UNR are
present in the ARS RNA–protein complex by gel-supershift
assaysandwehave coinedthe termARCforthisRNA–protein
complex. Both IMP1 and UNR can directly bind to the ARS
RNA but PABP has a stimulatory effect on their binding to the
ARS. This explains why depletion of PABP from the HeLa
cellextract almost abolishedbindingofthesetwopolypeptides
to the ARS. The precise RNA sequence within the ARS rec-
ognized by IMP1 and UNR is not known. However, our results
suggest that both polypeptides make contact with adenine
nucleotides since both polypeptides were detected by UV
crosslinking using [
32P]ATP labeled RNA. We had also
used [
32P]CTP or [
32P]UTP to label the ARS RNA and
used it for UV crosslinking studies. Both labeled RNAs
showed crosslinking to 72, 63 and 105 kDa polypeptides
(results not shown). Therefore, it is likely that these polypep-
tides make contact with a large region of the ARS. A 47 nt-
long domain of the ARS has been identiﬁed as the IMP1,
PABP and UNR binding region. Presence of the pyrimidine
stretches within this region is necessary for binding to IMP1
and UNR. Stimulation of the interactions of ARS with IMP1
and UNR by PABP also suggest a co-operative nature of
binding of these polypeptides to the ARS and formation of
a multicomponent RNP complex. To validate the results of in
vitro studies, we showed here that the ARS containing reporter
GFP mRNA, but not the wild-type GFP mRNA without the
ARS, can be immunoprecipitated with both the IMP1 and
UNR antibodies.
Althoughpresenceofalong(50ormore)stretchofadenines
at the 50-UTR of a reporter mRNA can repress translation (15),
this is not biologically relevant as a similar poly(A) sequence
has not been found in any PABP mRNA. The translational
control element present in human and other mammalian PABP
mRNA consists of several stretches of oligo(A)6–8 separated
by conserved pyrimidine bases. Therefore, it is important to
determine how the naturally occurring translational control
element of PABP mRNA functions. The evidences presented
in this manuscript suggest that the ARS forms a hetromeric
complex to repress translation. The need for the formation of a
multimeric RNP complex at the ARS for suppressing PABP
mRNA translation is further supported by two observations, (i)
that the ARS RNA is weaker than a similar size poly(A) RNA,
in its interaction with PABP (Figure 2) and (ii) the peptide
binding C-terminal PABC domain is required for the ARS
mediated translational control (15). Often, control of
mRNA translation is not an all or none phenomenon. The
degree to which the translation of a speciﬁc mRNA is regu-
lated depends on several factors including the availability of
translational repressors and enhancers, the mRNA and the
precise nature of its cis element.
IMP1 belongs to the VICKZ family of zipcode binding
proteins and is similar to chicken ZBPI (38,39) and Xenopus,
VgIRBP/vera (40). These groups of proteins are composed of
two RNA recognition motifs and four hn-RNP homology
domains. IMP1 is known to bind to the 50-UTR of IGF-II
mRNA to repress its translation (40). Like its ortholog chicken
ZBPI which is involved in the localization of b-actin mRNA to
the leading edge of ﬁbroblast cells, IMP1 is also implicated in
the subcytoplasmic localization of mRNAs (41,42). As a
modular protein IMP1 binds to various RNA sequences gen-
erally rich in A, U and C residues. Chicken ZBPI can be
crosslinked to RNA containing ACACCC sequences (39)
but its Xenopus ortholog, vera, binds to UUCAC and UUU-
CUA sequences of vg1 mRNA (40). The human IMP1 appears
to recognize the UUCACGUUCAC sequence in the 50-UTR of
IGF-II mRNA (40). Thus, the IMP1 binding domain of the
ARS is different from any previously characterized IMP1
binding sequence.
The third member of the ARC described in our studies is a
known PABP interacting protein UNR, which is also a RNA-
binding protein with ﬁve cold-shock domains (43–45). The
main cellular function of UNR includes internal initiation of
uncapped mRNA translation (46) and translation dependent
destabilization of mRNA (43). Recent studies have shown that
UNR is involved in the decay of c-fos mRNA through the
major protein-coding determinant of instability (mCRD).
UNR binds to both mCRD and PABP to form a platform
for the formation of a deadenylation/decay mRNA protein
complex (43). We showed that UNR also binds to the same
47 nt-long region of the ARS as IMP1 and PABP does. The
known UNR binding sequence of mCRD (43) and internal
ribosome entry site (46) are longer and more complex than
the UNR binding region of the ARS and bear no homology
with this region. Previously we showed that the ARS contain-
ing repressed and ARS minus reporter mRNAs have similar
half lives in transfected cells (24). Therefore, it is unlikely that
UNR is involved in destabilizing the ARS containing
repressed mRNA. Whether UNR is involved in any internal
initiation of PABP mRNA, which may impair proper initia-
tion, could be the subject for further investigation. As a PABP
interacting protein UNR could form a larger RNP complex
with the ARS than what could be achieved by PABP alone.
This larger RNP complex should be better able to prevent
movement of the scanning 40S subunits.
Analysis of various mutations of the ARS have shown that
binding of all three polypeptides, IMP1, PABP and UNR, are
similarly affected by these mutations. The presence of a four
oligo(A) rich stretches was shown to be sufﬁcient for both
ARC formation and repression of mRNA translation. In addi-
tion, the length of the spacer sequences between the oligo(A)s
is important for the function of ARS. In these studies we have
not tested whether the presence of T and Cs in the spacer is
also important. In this report we have mostly focused on dem-
onstrating the importance of ARC formation for repression of
mRNA translation. The three polypeptides present in the ARC
are RNA-binding polypeptides, which can also interact with
other polypeptides (17,44,45). Whether a larger RNP is
formed with the ARS through protein–protein interactions
with the core RNP complex needs to be further investigated.
The presence of several additional ARS speciﬁc polypeptides
in the afﬁnity puriﬁed sample (Figure 3) supports the forma-
tion of a large multimeric complex with the ARS through both
RNA–protein and protein–protein interactions.
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